[ad_1]
Pfizer Inc. said last month that it expected to deliver half of the Covid-19 vaccines it had originally planned for this year, his decision made clear the challenges faced by pharmaceutical companies to meet high demand and shorter lead times, while offering a product that is too complex to stock, The Wall magazine reported.
The Pfizer / BioNTech vaccine requires long-term storage at a temperature of -70 degrees Celsius, which is a serious logistical challenge for the countries. However, Pfizer / BioNTech states that their vaccine can be stored for up to five days in the refrigerator at 2 to 8 degrees Celsius.
Pfizer and Germany-based partner BioNTech SE expected to launch 100 million vaccines worldwide by the end of this year – plan, which was cut to $ 50 million on Nov.9.
Pfizer is still waiting to launch more 1 billion doses in 2021, as originally planned.
However, a company spokesperson warned that the production process would take longer than planned.
We remind you that yesterday Bahrain became the second country in the world to approve the vaccine from Pfizer / BioNTech after Great Britain.
Bahrain is the second country in the world to approve the Pfizer / BioNTech vaccine
In November, the Persian state also approved the vaccine from a Chinese company
In November, the Persian state also approved the coronavirus vaccine from Chinese pharmaceutical company Sinopharm. The vaccine is given to front-line workers in the fight against the virus.
A few days ago Great Britain became the first country in the world to approve the Pfizer / BioNTech vaccine.
Analysis of the results of a large clinical trial showed that the vaccine was 95% effective against coronavirus and it does not cause serious side effects.
Pharmaceutical giant Pfizer is slashing its launch target for its Covid-19 vaccine in half as unexpected delays affect production and distribution. How big of a setback is this news from Pfizer?
Dr. @ashishkjha discusses the concerns Americans may have.# COVID-19 #Vaccines for COVID-19 #Pfizer pic.twitter.com/5rdG4WPZ0h
– WSJ in general (@WSJatLarge) December 4, 2020
The US Food and Drug Administration, where such a permit can be issued later this month and put into service before the end of the year.
Leading expert Anthony Fauci has already criticized Britain for rushing to approve the vaccine.
We remind you that Bulgaria too to receive the Pfizer coronavirus vaccine. Her 125,000 doses will arrive first. We are interested in the vaccines of 3 more companies.
[ad_2]
